• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Joseph Dowling

Recent news which mentions Joseph Dowling

Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know
November 22, 2024
Tickers CBD CVSI HEMP NEWS
Tags CBD M&A Extract Labs
From Benzinga
CV Sciences Q3: Revenue Stable Amid New Launches, Financing
November 14, 2024
Tickers CVSI HEMP
Tags CVSI Joseph Dowling Market News
From Benzinga
Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2
August 13, 2024
Tickers CVSI NEWS
Tags News financial statements Cannabis
From Benzinga
Hemp-Focused CV Sciences Reports Steady Q1 Revenue Amid Operational Hurdles And Acquisition Of Nutraceuticals Manufacturer
May 14, 2024
Tickers CVSI HEMP
Tags Cannabis Earnings Hemp Benzinga
From Benzinga
Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit
March 28, 2024
Tickers CVSI HEMP NEWS
Tags Joseph Dowling financial results CVSI
From Benzinga
Capitalizing On Plant-Based Trend: Cultured Foods Acquisition Allows This US Hemp Co. To Expand In Europe
December 12, 2023
Tickers CVSI HEMP
Tags Hemp Benzinga Cannabis
From Benzinga
Hemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%
November 14, 2023
Tickers CVSI
Tags Markets Inc/ Earnings
From Benzinga
Publicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Know
August 14, 2023
Tickers CVSI
Tags Market News Earnings Markets
From Benzinga
CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know
May 15, 2023
Tickers CVSI
Tags Cannabis News Benzinga
From Benzinga
CV Sciences FY22 Revenue Declines 19% To $16.2M
March 29, 2023
Tickers CVSI
Tags Joseph Dowling CVSI Penny Stocks
From Benzinga
CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next
March 23, 2023
Tickers CVSI
Tags News Cannabis premium
From Benzinga
Why Is CV Sciences Stock Up Today?
November 14, 2022
Tickers CVSI
Tags CVSI Markets Penny Stocks
From Benzinga
CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share
May 16, 2022
Tickers CVSI
Tags Joseph Dowling CVSI Penny Stocks
From Benzinga
CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products
March 08, 2022
Tickers CVSI
Tags Benzinga News Cannabis
From Benzinga
CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
January 11, 2022
Tickers CVSI
Tags Markets CBD Topicals CBD for Arthritis Patients
From Benzinga
CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
November 15, 2021
Tickers CVSI
Tags Penny Stocks CVSI Joseph Dowling
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap